A-197

N/A

Report date: 2022/11/07 13:27:13
NMEFirst In Class

Base Information

Drug NameA-197
Drug Alias NameA-197
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHelper-inducer T-lymphocytes inhibitorsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDry Eye SyndromesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici SpaAramis Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAramis Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A